Posterior chamber phakic intraocular lens for hyperopia of +4 to +11 diopters

To examine the efficacy, predictability, stability, and safety of posterior chamber phakic intraocular lens (IOL) implantation in eyes with high hyperopia.

We analyzed the results of 24 eyes that received a posterior chamber hydrogel-collagen plate phakic IOL (Staar Collamer Implantable Contact Lens, ICL) for the correction of hyperopia with the goal of emmetropia. Mean follow-up was 8.4 months (range, 1 to 18 mo).

The mean preoperative spherical equivalent refraction was +6.51 +/- 2.08 D (range, +3.75 to +10.50 D). Mean postoperative spherical equivalent refraction at last examination was -0.39 +/- 1.29 D (range, +1.25 to -3.88 D), with 79% (19 eyes) within +/-1.00 D and 58% (14 eyes) within +/-0.50 D of emmetropia. Postoperative uncorrected visual acuity at last examination was 20/20 or better in 8% (two eyes) and 20/40 or better in 63% (15 eyes). A gain of two or more lines of spectacle-corrected visual acuity was seen in two eyes (8%) at last examination. One eye (4%) lost two or more lines of spectacle-corrected visual acuity due to progressive neovascular glaucoma initiated by early postoperative pupillary block.

Posterior chamber phakic IOL implantation with the Staar Collamer plate lens is an effective method for correcting high hyperopia. Large, patent iridotomies are important in hyperopic eyes to lower the risk of postoperative pupillary block. Improved phakic IOL power calculation formulas will refine predictability of refractive outcome.